Cargando…

5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis

OBJECTIVE: To assess the relationship between 5α-reductase inhibitors (5ARIs) and the risk of male breast cancer (MBC). MATERIAL AND METHODS: We systematically searched Medline via PubMed, Embase and the Cochrane Library Central Register up to May 2017 to identify published articles related to 5ARIs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiamin, Zhao, Shankun, Luo, Lianmin, Li, Ermao, Li, Xiaohang, Zhao, ZhiGang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Urologia 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237523/ https://www.ncbi.nlm.nih.gov/pubmed/29697934 http://dx.doi.org/10.1590/S1677-5538.IBJU.2017.0531

Ejemplares similares

Dorsal penile nerve block versus eutectic mixture of local anesthetics cream for pain relief in infants during circumcision: A meta-analysis
por: Wang, Jiamin, et al.
Publicado: (2018)

Shengjing Capsule Improves Spermatogenesis through Upregulating Integrin α6/β1 in the NOA Rats
por: Wang, Jiamin, et al.
Publicado: (2019)

High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis
por: Zhao, Shankun, et al.
Publicado: (2019)

Bone marrow mesenchymal stem cells reduce ureteral stricture formation in a rat model via the paracrine effect of extracellular vesicles
por: Luo, Jintai, et al.
Publicado: (2018)

Comparison of two cannulation methods for assessment of intracavernosal pressure in a rat model
por: Zhao, Shankun, et al.
Publicado: (2018)

Low intensity extracorporeal shockwave Therapy shifts PDE5i nonresponders to responders
por: Wang, Jiamin, et al.
Publicado: (2020)

Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells
por: Kang, Ran, et al.
Publicado: (2016)

miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition
por: Zhao, Zhigang, et al.
Publicado: (2020)

Correction: miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition
por: Zhao, Zhigang, et al.
Publicado: (2021)

MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13
por: Liu, Yangzhou, et al.
Publicado: (2021)

Mesenchymal stem cell‐derived exosomes ameliorate erection by reducing oxidative stress damage of corpus cavernosum in a rat model of artery injury
por: Liu, Yangzhou, et al.
Publicado: (2019)

Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis
por: Hu, Xu, et al.
Publicado: (2020)

Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
por: Kim, Jae Heon, et al.
Publicado: (2020)

Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis
por: Zhu, Zhiguo, et al.
Publicado: (2020)

Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis
por: Deng, Tuo, et al.
Publicado: (2020)

Role of 5 alpha-reductase inhibitors in the management of prostate cancer
por: Hudak, Steven J, et al.
Publicado: (2006)

Prostate Cancer Mortality and Use of 5-Alpha Reductase Inhibitors
por: Foldes, Cara A., et al.
Publicado: (2020)

5-alpha reductase inhibitors use in prostatic disease and beyond
por: Chislett, Bodie, et al.
Publicado: (2023)

MiRNA-671-5p Promotes prostate cancer development and metastasis by targeting NFIA/CRYAB axis
por: Zhu, Zhiguo, et al.
Publicado: (2020)

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
por: Robinson, David, et al.
Publicado: (2015)

Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
por: Kim, Jae Heon, et al.
Publicado: (2018)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
por: Escamilla-Cruz, Mariana, et al.
Publicado: (2023)

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia
por: Hagberg, Katrina Wilcox, et al.
Publicado: (2017)

Association between 5α-reductase inhibitors therapy and incidence, cancer-specific mortality, and progression of prostate cancer: evidence from a meta-analysis
por: Luo, Lian-Min, et al.
Publicado: (2019)

Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats
por: Aloisi, Anna Maria, et al.
Publicado: (2010)

5-alpha-reductase and the development of the human prostate
por: Radmayr, C., et al.
Publicado: (2008)

Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
por: Kim, Min-Woo, et al.
Publicado: (2017)

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia
por: Cho, Kang Jun, et al.
Publicado: (2011)

Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia
por: Kim, Won, et al.
Publicado: (2014)

Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
por: Choi, Gwang Seong, et al.
Publicado: (2016)

5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
por: Wang, Ziting, et al.
Publicado: (2023)

Is Transforming Growth Factor-β Signaling Activated in Human Hypertrophied Prostate Treated by 5-Alpha Reductase Inhibitor?
por: Kim, Hye Kyung, et al.
Publicado: (2013)

May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
por: Adamowicz, Jan, et al.
Publicado: (2020)

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
por: Falagario, Ugo G., et al.
Publicado: (2023)

The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
por: Ayodele, Olulade, et al.
Publicado: (2021)

The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer
por: Xiang, Qian, et al.
Publicado: (2020)

Association of 5α-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea
por: An, Min Ho, et al.
Publicado: (2023)

Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
por: Sung, Hyun Hwan, et al.
Publicado: (2019)

5-Alpha-Reductase 2 Deficiency in a Woman with Primary Amenorrhea
por: Maleki, Nasrollah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ud34jq7l9bf88tme02v70v1cfs